Ticker brief
ABT ABBOTT LABORATORIES .
Consumer, Non-cyclical · Healthcare-Products
last close
$112.47
1 day
+0.8%
14 days
+1.1%
mkt cap
$166.2B
signals 14d
16
authors 14d
12
crowd 14d
+0.9σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 28% mid · 75 pctile own 1y | IV/HV 0.96× (as of 2026-07-31) |
| Skew — 25Δ RR 30d | -0.001 96 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.17 elevated | 5-session Δ +0.04 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-05-12 (z=2.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-27 · now +0.50 (−1 bearish … +1 bullish)
Who spoke12
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @tenet_research | C | -0.96 | 3 | +0.37 |
| @BeatTheInsider | C | · | 2 | -0.20 |
| @MarketNews_Feed | C | · | 2 | -0.05 |
| @BrandonVanZee | C | -0.31 | 1 | +0.00 |
| @ThePupOfWallSt | C | -0.47 | 1 | +0.00 |
| @PolycarpFX | B | +1.12 | 1 | +0.25 |
| @capitol2iq | C | · | 1 | -0.20 |
| @MR_Stock10 | C | +0.46 | 1 | +0.70 |
| @tradealgo_ | C | -1.28 | 1 | +0.00 |
| @TalkMarkets | C | · | 1 | +0.45 |
| @CrweWorld | C | · | 1 | +0.50 |
| @financespotnews | C | -3.33 | 1 | +0.50 |
Recent signals16of 16 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @financespotnews | +0.50 | FDA clears Abbott's Libre Duo dual glucose-ketone wearable sensor. | +0.8% | tweet ↗ |
| 2026-08-25 | @CrweWorld | +0.50 | The FDA authorized Abbott's wearable device for continuous ketone and blood-sugar monitoring. | -3.2% | tweet ↗ |
| 2026-08-25 | @tenet_research | +0.50 | Abbott receives FDA authorization for a dual glucose-ketone sensor. | -3.2% | tweet ↗ |
| 2026-08-25 | @tenet_research | +0.50 | FDA clears Abbott's first-in-US continuous dual glucose-ketone monitor. | -3.2% | tweet ↗ |
| 2026-08-24 | @TalkMarkets | +0.45 | States momentum is rotating into biotechnology and healthcare. | -3.6% | tweet ↗ |
| 2026-08-24 | @tradealgo_ | +0.00 | ABT dark-pool volume was $769K, or 7.1 times normal activity. | -3.6% | tweet ↗ |
| 2026-08-23 | @MR_Stock10 | +0.70 | Celebrates ABT reaching a prior chart target for a 42% gain. | -3.6% | tweet ↗ |
| 2026-08-20 | @MarketNews_Feed | -0.30 | Abbott still faces about 1,700 lawsuits concerning claims involving 12,700 infants. | -1.5% | tweet ↗ |
| 2026-08-20 | @MarketNews_Feed | +0.20 | Abbott will pay about $670M to settle the Gill case and roughly 2,000 related formula claims. | -1.5% | tweet ↗ |
| 2026-08-19 | @capitol2iq | -0.20 | Reports a lawmaker spouse selling Abbott and buying AMD and Broadcom. | -1.7% | tweet ↗ |
| 2026-08-19 | @BeatTheInsider | -0.20 | Reports a politician's disclosure highlighting AMD and AVGO purchases and an ABT sale. | -1.7% | tweet ↗ |
| 2026-08-18 | @PolycarpFX | +0.25 | Suggests MDT and ABT are positioned before a move, but provides no mechanics or supporting context. | -0.2% | tweet ↗ |
| 2026-08-18 | @ThePupOfWallSt | +0.00 | Reports unusual dark-pool prints at 10–15 times daily average volume. | -0.2% | tweet ↗ |
| 2026-08-17 | @tenet_research | +0.10 | Abbott and NACHC launch a nationwide Food for Health initiative. | +1.9% | tweet ↗ |
| 2026-08-17 | @BeatTheInsider | -0.20 | Reports a political financial disclosure highlighting BRK.B and sales across several named stocks. | +1.9% | tweet ↗ |
| 2026-08-17 | @BrandonVanZee | +0.00 | Lists dividend-growth stocks with dividend pay dates on August 17; output is capped at six tickers. | +1.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.